Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Molecular Biology

• Publication date

  2010-03-19

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jmb.2010.01.046PMID 20114052
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Insertion and Transport of Anandamide in Synthetic Lipid Membranes Are Both Cholesterol-Dependent

  2009cited by this paper
• Gangliosides determine the amyloid pathology of Alzheimer's disease

  2009cited by this paper
• Surface chemistry of Alzheimer's disease: a Langmuir monolayer approach.

  2009cited by this paper
• Driving force of binding of amyloid beta-protein to lipid bilayers.

  2008cited by this paper
• Impact of Tyr to Ala mutations on alpha-synuclein fibrillation and structural properties.

  2008cited by this paper
• Alpha-Synuclein conformation affects its tyrosine-dependent oxidative aggregation.

  2008cited by this paper
• Using model membranes for the study of amyloid beta:lipid interactions and neurotoxicity

  2008cited by this paper
• Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains.

  2008cited by this paper
• Origins and effects of extracellular alpha-synuclein: implications in Parkinson's disease.

  2008cited by this paper
• Mechanistic aspects of Parkinson’s disease: α-synuclein and the biomembrane

  2007cited by this paper
• GM1 Specifically Interacts with α-Synuclein and Inhibits Fibrillation†

  2007cited by this paper
• Helical α-Synuclein Forms Highly Conductive Ion Channels†

  2007cited by this paper
• GM1 specifically interacts with alpha-synuclein and inhibits fibrillation.

  2007cited by this paper
• Helical alpha-synuclein forms highly conductive ion channels.

  2007cited by this paper
• Origins and Effects of Extracellular α-synuclein: Implications in Parkinson’s Disease

  2007cited by this paper
• Interaction of proteins with lipid rafts through glycolipid-binding domains: biochemical background and potential therapeutic applications.

  2007cited by this paper
• Mechanistic aspects of Parkinson's disease: alpha-synuclein and the biomembrane.

  2007cited by this paper
• Alzheimer's disease beta-amyloid peptides are released in association with exosomes.

  2006cited by this paper
• The minimal amyloid‐forming fragment of the islet amyloid polypeptide is a glycolipid‐binding domain

  2006cited by this paper
• Plasma membrane ion permeability induced by mutant α‐synuclein contributes to the degeneration of neural cells

  2006cited by this paper
• Prediction of glycolipid-binding domains from the amino acid sequence of lipid raft-associated proteins: application to HpaA, a protein involved in the adhesion of Helicobacter pylori to gastrointestinal cells.

  2006cited by this paper
• Ganglioside GM3 is involved in neuronal cell death

  2006cited by this paper
• The role of lipid-protein interactions in amyloid-type protein fibril formation.

  2006cited by this paper
• Amyloid ion channels: a common structural link for protein-misfolding disease.

  2005cited by this paper
• Host sphingolipid biosynthesis as a target for hepatitis C virus therapy

  2005cited by this paper
• Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein.

  2005cited by this paper
• Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins

  2005cited by this paper
• The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia

  2004cited by this paper
• Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase

  2004cited by this paper
• α‐Synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma

  2003cited by this paper
• Membrane-bound α-Synuclein Has a High Aggregation Propensity and the Ability to Seed the Aggregation of the Cytosolic Form*

  2002cited by this paper
• Study on the insertion process of human apolipoprotein H into spread phospholipid monolayers by monitoring the initial change in surface pressure

  2002cited by this paper
• Climate change (Communication arising): Recent temperature trends in the Antarctic

  2002cited by this paper
• Biophysical Properties of the Synucleins and Their Propensities to Fibrillate

  2002cited by this paper
• Identification of a Common Sphingolipid-binding Domain in Alzheimer, Prion, and HIV-1 Proteins*

  2002cited by this paper
• Neurodegenerative disease: Amyloid pores from pathogenic mutations

  2002cited by this paper
• Lipid rafts: structure, function and role in HIV, Alzheimer's and prion diseases

  2002cited by this paper
• Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology.

  2001cited by this paper
• Solvent-induced collapse of alpha-synuclein and acid-denatured cytochrome c.

  2001cited by this paper
• Solvent‐induced collapse of α‐synuclein and acid‐denatured cytochrome c

  2001cited by this paper
• Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology

  2001cited by this paper
• Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects.

  2000cited by this paper
• alpha-Synuclein membrane interactions and lipid specificity.

  2000cited by this paper
• α-Synuclein Membrane Interactions and Lipid Specificity*

  2000cited by this paper
• Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects

  2000cited by this paper
• Amyloid beta protein (1-40) forms calcium-permeable, Zn2+-sensitive channel in reconstituted lipid vesicles.

  1999cited by this paper
• Sulfatide inhibits HIV-1 entry into CD4-/CXCR4+ cells.

  1998cited by this paper
• Specific Interaction of HIV-1 and HIV-2 Surface Envelope Glycoproteins with Monolayers of Galactosylceramide and Ganglioside GM3*

  1998cited by this paper
• Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes*

  1998cited by this paper
• Protein structure alignment by incremental combinatorial extension (CE) of the optimal path.

  1998cited by this paper
• SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling

  1997cited by this paper
• Acceleration of Amyloid Fibril Formation by Specific Binding of Aβ-(1–40) Peptide to Ganglioside-containing Membrane Vesicles*

  1997cited by this paper
• Ion-channel-forming colicins.

  1995cited by this paper
• Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes.

  1995cited by this paper
• Membrane Lipids of Adult Human Brain: Lipid Composition of Frontal and Temporal Lobe in Subjects of Age 20 to 100 Years

  1994cited by this paper
• Ion channels on synaptic vesicle membranes studied by planar lipid bilayer method.

  1992cited by this paper
• Gangliosides and synaptic transmission.

  1990cited by this paper

• Preclinical assessment of a ganglioside-targeted therapy for Parkinson’s disease with the first-in-class adaptive peptide AmyP53

  2025cites this paper
• GM1 and OligoGM1 Drive Divergent α-Synuclein Aggregation Pathways.

  2025cites this paper
• Glycosphingolipids in neurodegeneration - Molecular mechanisms, cellular roles, and therapeutic perspectives.

  2025cites this paper
• Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson’s Disease

  2022influential citation
• Electrochemical assessment of dielectric damage to phospholipid bilayers by amyloid β-Oligomers.

  2022cites this paper
• Neurons and Glia Interplay in α-Synucleinopathies

  2021cites this paper
• Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson’s disease

  2021cites this paper
• The Involvement of Lactosylceramide in Central Nervous System Inflammation Related to Neurodegenerative Disease

  2021influential citation
• Overview of sialylation status in human nervous and skeletal muscle tissues during aging.

  2021cites this paper
• Alteration in the cerebrospinal fluid lipidome in Parkinson´s disease: A pilot study

  2021cites this paper
• Lipids: biomarkers of healthy aging

  2021cites this paper
• Lipidomics Prediction of Parkinson’s Disease Severity: A Machine-Learning Analysis

  2021cites this paper
• Alteration in the Cerebrospinal Fluid Lipidome in Parkinson’s Disease: A Post-Mortem Pilot Study

  2021cites this paper
• Genetic perspective on the synergistic connection between vesicular transport, lysosomal and mitochondrial pathways associated with Parkinson’s disease pathogenesis

  2020cites this paper
• The GSL-Dependent Signaling

  2020cites this paper
• Model for the Transfer of Ca2+ from Outside the Cell to Inside the Cell with Bovine Milk Component to Justify Its Use as an Alzheimer’s Treatment

  2020cites this paper
• Extracellular vesicle-associated lipids in central nervous system disorders.

  2020cites this paper
• The Role of Lipids in Parkinson’s Disease

  2019cites this paper
• Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease

  2019influential citation
• The role of lipids in α-synuclein misfolding and neurotoxicity

  2019cites this paper
• Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration

  2018cites this paper
• Insights into the Molecular Mechanisms of Alzheimer’s and Parkinson’s Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology

  2018cites this paper
• Estrogen Interactions With Lipid Rafts Related to Neuroprotection. Impact of Brain Ageing and Menopause

  2018cites this paper
• Alpha-synuclein at the intracellular and the extracellular side: functional and dysfunctional implications

  2017cites this paper
• Elevated GM3 plasma concentration in idiopathic Parkinson’s disease: A lipidomic analysis

  2017cites this paper
• Cellular Regulation of Amyloid Formation in Aging and Disease

  2017cites this paper
• High Performance Liquid Chromatography-Mass Spectrometry (LC-MS) Based Quantitative Lipidomics Study of Ganglioside-NANA-3 Plasma to Establish Its Association with Parkinson’s Disease Patients

  2017cites this paper
• Physico-Pathologic Mechanisms Involved in Neurodegeneration: Misfolded Protein-Plasma Membrane Interactions.

  2017cites this paper
• Regulation of Amyloid Formation in Aging and Disease

  2017cites this paper
• Detection of misfolded protein aggregates from a clinical perspective

  2016cites this paper
• Quantification of monosialogangliosides in human plasma through chemical derivatization for signal enhancement in LC-ESI-MS.

  2016cites this paper
• Membrane raft domains and remodeling in aging brain.

  2016cites this paper
• Interaction of α-synuclein with biomembranes in Parkinson's disease--role of cardiolipin.

  2016cites this paper
• Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosides.

  2016influential citation
• Linear dichroism spectroscopy and biophysics of an amyloid protein

  2015cites this paper
• Molecular determinants of α-synuclein mutants' oligomerization and membrane interactions.

  2015cites this paper
• Gangliosides: glycosphingolipids essential for normal neural development and function.

  2015cites this paper
• α‐Synuclein forms non‐selective cation channels and stimulates ATP‐sensitive potassium channels in hippocampal neurons

  2015cites this paper
• Protein Mis-Termination Initiates Genetic Diseases, Cancers, and Restricts Bacterial Genome Expansion

  2015cites this paper
• Chapter 10 – Parkinson’s Disease

  2015cites this paper
• Alpha-Synuclein Function and Dysfunction on Cellular Membranes

  2014influential citation
• Interaction of Alzheimer's β-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation.

  2014cites this paper
• GM1 and GM2 gangliosides: recent developments

  2014cites this paper
• A new liquid chromatography/tandem mass spectrometry method for quantification of gangliosides in human plasma.

  2014cites this paper
• Cerebrospinal Fluid Lysosomal Enzymes and Alpha-Synuclein in Parkinson's Disease

  2014influential citation
• Lipid-mediated Protein Signaling

  2013cites this paper
• Biochemical identification of a linear cholesterol-binding domain within Alzheimer's β amyloid peptide.

  2013cites this paper
• The driving force of alpha-synuclein insertion and amyloid channel formation in the plasma membrane of neural cells: key role of ganglioside- and cholesterol-binding domains.

  2013cites this paper
• Glucocerebrosidase mutations and Parkinson's disease

  2013cites this paper
• Alpha-synuclein pore forming activity upon membrane association.

  2012cites this paper
• Membrane pores in the pathogenesis of neurodegenerative disease.

  2012cites this paper
• Overview of Fibrillar and Oligomeric Assemblies of Amyloidogenic Proteins

  2012cites this paper
• Determination of disialoganglioside GD3 and monosialoganglioside GM3 in infant formulas and whey protein concentrates by ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry.

  2012cites this paper
• Glycosphingolipids in signaling and development: From liposomes to model organisms

  2012cites this paper
• 5 Alpha-Synuclein Interactions with Membranes

  2012cites this paper
• Structural and molecular basis of carbohydrate-protein interaction systems as potential therapeutic targets.

  2011cites this paper
• Structural and Functional Insights into α‐Synuclein–Lipid Interactions

  2011cites this paper
• Alpha-Synuclein Interactions with Membranes

  2011cites this paper
• Molecular basis for the glycosphingolipid-binding specificity of α-synuclein: key role of tyrosine 39 in membrane insertion.

  2011cites this paper
• The fusogenic tilted peptide (67-78) of α-synuclein is a cholesterol binding domain.

  2011cites this paper
• Membrane Incorporation, Channel Formation, and Disruption of Calcium Homeostasis by Alzheimer's β-Amyloid Protein

  2011cites this paper
• Familial Parkinson's Disease Mutant E46K α-Synuclein Localizes to Membranous Structures, Forms Aggregates, and Induces Toxicity in Yeast Models

  2011cites this paper
• Gangliosides as a Double-Edged Swordin Neurodegenerative Disease

  2011cites this paper
• Conserved core of amyloid fibrils of wild type and A30P mutant α‐synuclein

  2011cites this paper
• The role of glycosphingolipids in HIV/AIDS.

  2011cites this paper
• Glycosphingolipid functions.

  2011cites this paper
• Lipid Classes and Fatty Acid Patterns are Altered in the Brain of γ-Synuclein Null Mutant Mice

  2010cites this paper
• Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases

  2010cites this paper